Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
36.91
-0.61 (-1.63%)
At close: Oct 30, 2026, 4:00 PM EDT
37.00
+0.09 (0.24%)
After-hours: Oct 30, 2026, 7:53 PM EDT
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $26.66 billion as of October 30, 2026. It is the 929th most valuable company in the world and the 399th biggest in the United States. Its market cap has increased by 105.70% in one year.
Market Cap
26.66B
Enterprise Value
22.93B
1-Year Change
105.70%
Global Rank
Country Rank
#399 United States
Category
ChartMarket Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $26.66B, an increase of 4,898.52%. That is a compound annual growth rate of 94.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 26.66B | 76.65% |
| Dec 31, 2025 | 15.09B | 75.25% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 42.25B |
| Revolution Medicines | 40.78B |
| Royalty Pharma | 37.91B |
| Genmab | 33.33B |
| Insmed | 24.37B |
| Incyte | 23.68B |
| Alnylam Pharmaceuticals | 23.28B |
| BioNTech SE | 22.39B |